Support and Resistance Levels
Past performance
About Dr Agarwals Health Care Ltd Dr. Agarwal's Health Care Limited, incorporated in 2010, is a leading provider of eye care services and products. The company focuses on a comprehensive range of treatments, including surgical procedures like cataract, corneal, retinal, refractive surgeries, and advanced capabilities such as LASIK and cornea transplantation. Its offerings extend to consultations, non-surgical treatments, optical products, and pharmaceuticals, catering to diverse eye care needs.
The company has steadily expanded its operations since inception. It entered Telangana and Karnataka markets in 2010 and ventured into Africa in 2012, where it now operates 15 facilities providing advanced eye care services, including pediatric and neuro-ophthalmological treatments. Dr. Agarwal's achieved significant milestones, such as launching its 100th eye care facility in 2021. The company further accelerated growth by acquiring businesses in key regions like Maharashtra (2017), Gujarat (2022), and Punjab and Uttar Pradesh (2023-2024), solidifying its footprint across India.
Dr. Agarwal's growth strategy highlights both organic and inorganic expansions, enabling it to cater to a growing demand for specialized eye care services. Apart from its domestic presence, its international operations position it as a significant player in the broader eye care market.
The company is preparing for an Initial Public Offering (IPO) to raise Rs 300 crore through fresh equity issuance and offer additional shares through an Offer for Sale. This fundraising is expected to support its continued expansion and operational growth, making it an attractive prospect for traders seeking exposure to the health care sector.